Part A of this bill makes the following changes to the Maine Medical Use of Cannabis Act.
1. It defines the terms "batch," "cannabis," "cannabis flower," "cannabis trim," "matrix," "remediation," "testing" and "THC" and repeals and replaces the definition of "cannabis testing facility."
2. It clarifies that only cannabis testing facilities may conduct testing for research and development purposes.
3. It establishes a program for the mandatory testing of harvested cannabis.
4. It replaces previous authorization for cannabis testing facilities with a provision establishing the cannabis testing facility registration type and identifies additional requirements necessary to obtain a registration certificate to operate a cannabis testing facility.
5. It includes cannabis testing facilities in the standard application process for a registration certificate.
6. It requires the testing of all harvested cannabis provided to a qualifying patient by a registrant.
7. It requires mandatory testing of harvested cannabis for the presence of harmful contaminants and the cannabinoid profiles.
8. It requires reporting of mandatory test results to the Department of Administrative and Financial Services, Office of Cannabis Policy and the registrant that submitted samples to a cannabis testing facility for testing.
9. It establishes sampling requirements and permits the office to take samples for audit testing to verify mandatory test results and to ensure the quality, consistency and reliability of the testing program.
10. It identifies the circumstances in which additional mandatory testing is not required before harvested cannabis is provided to a qualifying patient.
11. It revises reporting and record-keeping requirements to require records retention for 6 years and to mandate that all registrants report all required inventory information in the statewide inventory tracking system implemented and administered by the office.
12. It adds requirements and health and safety rules to the provisions on packaging and labeling.
13. It repeals the provision that prohibits certain parties from having financial or other interest in testing facility product labeling. Part B of the bill makes the following changes to the Cannabis Legalization Act.
1. It adds a definition of "matrix."
2. It identifies what tests for harmful contaminants are mandatory for adult use cannabis and adult use cannabis products based upon the matrix the cannabis or cannabis product is in at the time it is subject to mandatory testing.

Statutes affected:
Bill Text LD 104, HP 69: 22.2421, 22.2423, 22.2425, 22.2428, 22.2429, 22.2430, 28-B.102, 28-B.602